Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines.
about
Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivoHost Immunological Factors Enhancing Mortality of Young Adults during the 1918 Influenza PandemicB Cells and Functional Antibody Responses to Combat InfluenzaTwo years after pandemic influenza A/2009/H1N1: what have we learned?Immune history shapes specificity of pandemic H1N1 influenza antibody responses.Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis.Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus.Evaluation of neutralizing efficacy of monoclonal antibodies specific for 2009 pandemic H1N1 influenza A virus in vitro and in vivo.Modified vaccinia virus Ankara expressing the hemagglutinin of pandemic (H1N1) 2009 virus induces cross-protective immunity against Eurasian 'avian-like' H1N1 swine viruses in mice.DBA/2 mouse as an animal model for anti-influenza drug efficacy evaluation.Divergent H7 immunogens offer protection from H7N9 virus challenge.Humanized antibody neutralizing 2009 pandemic H1N1 virus.Influenza A virus acquires enhanced pathogenicity and transmissibility after serial passages in swineChemical-free inactivated whole influenza virus vaccine prepared by ultrashort pulsed laser treatmentBroadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.Immunological characterization of monoclonal antibodies used in rapid influenza diagnostic test for detection of the 2009 pandemic influenza A(H1N1)pdm09 infection.Computational studies of pandemic 1918 and 2009 H1N1 hemagglutinins bound to avian and human receptor analogs.A comprehensive collection of systems biology data characterizing the host response to viral infection.Cross-protection against European swine influenza viruses in the context of infection immunity against the 2009 pandemic H1N1 virus: studies in the pig model of influenza.Infection in Health Personnel with High and Low Levels of Exposure in a Hospital Setting during the H1N1 2009 Influenza A PandemicCross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design.Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 proteinImmunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus.Protection from the 2009 H1N1 pandemic influenza by an antibody from combinatorial survivor-based librariesOseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models.Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner.Classical swine H1N1 influenza viruses confer cross protection from swine-origin 2009 pandemic H1N1 influenza virus infection in mice and ferrets.Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses.Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus.T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model.Genetic and antigenic characterization of H1 influenza viruses from United States swine from 2008.Virulence determinants of pandemic influenza viruses.Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection.Synergy between the classical and alternative pathways of complement is essential for conferring effective protection against the pandemic influenza A(H1N1) 2009 virus infection.Vaccinate for the next H2N2 pandemic now.The first influenza pandemic of the new millennium.Immunization with 1976 swine H1N1- or 2009 pandemic H1N1-inactivated vaccines protects mice from a lethal 1918 influenza infectionCross-neutralizing antibodies to pandemic 2009 H1N1 and recent seasonal H1N1 influenza A strains influenced by a mutation in hemagglutinin subunit 2.Differential host determinants contribute to the pathogenesis of 2009 pandemic H1N1 and human H5N1 influenza A viruses in experimental mouse models.Influenza A viruses: new research developments.
P2860
Q24568302-FC5956A9-57F5-420E-8CEE-1C5519CA0066Q26782795-710AF8E3-7ED8-4035-B25F-C03D4140CFA1Q26801639-E402E58A-D7A9-410D-AC25-E2EC5019AC26Q30224656-F1393D2F-0C2F-46FB-868F-FD9589D505EFQ30352126-D288CCD7-558D-49B3-BEB3-405C8296AECFQ30352862-127B6944-2B9B-4D75-B1E8-EC6EBE16493AQ30353786-BF634EDA-0683-4D5C-B1E1-64D64640D8DCQ30353823-657CFB5C-D863-4851-86B9-0AE02F70C5ADQ30357331-5FBB9726-D7BB-49B0-A3A6-671ED7D6534CQ30357472-B179602D-266E-4AD5-88F2-3A03DE7DEACAQ30358196-9EC0EB56-5573-49F1-8062-66D711F7C52EQ30364911-FBA434F7-4E21-44BE-AE60-9298897C4756Q30365481-469A8311-9F69-4E32-A074-55A3EA7C8694Q30368920-A07FF06C-5B68-4C4F-B9D8-B2E543CE5D42Q30370793-0E13DA19-EABB-4C7D-93D0-3E8141EFDCD9Q30371141-126FC760-3EDF-4F68-9401-C330840EDBE1Q30373950-06657564-7AAC-4685-8EFF-22F9F860E3A5Q30374709-87702063-8119-46FF-B5A4-0CDDB740224FQ30379517-CAC051CA-21B0-451D-883C-6000DD06A202Q30383772-52B7C843-9CE0-4E37-88E7-F821C04B2AECQ30387829-AB193121-37A1-44AA-B636-5504DB34D675Q30388846-DDDE1459-EF04-46DC-A97E-5277F0FF7EE0Q30390815-10F77892-140B-470D-ACCA-6BF26B90FDB0Q30391350-4741FDC4-A22C-4075-9A95-1FF2A31A00F0Q30392964-B574F685-BED5-40E3-B0D9-A42CBD5FF47FQ30393724-5F3D8091-36D7-4952-8191-2461AC4CC2FBQ30394606-6B91F888-EE0F-4731-91E1-DCB1F9B7BD6FQ30395088-74FEF7EE-C6E3-4559-97A4-395092405C9AQ30395264-6D8128F7-8D4E-4E2D-BE41-1313F47B4B4DQ30395346-92255006-22EF-4D8F-ADEB-0EFDA2444149Q30397785-A55F0424-E939-48FC-811C-3398D8DBD886Q30398168-420FC8E4-C606-4AE3-BC74-41693B7FFEAAQ30398435-EAC658AD-5882-49BB-B0F5-660CFA3A8319Q30399993-123909E6-B879-47FE-83FA-BFB04BE6F891Q30400584-6DCB10BB-09E7-4EBD-8761-2460FA6D56ECQ30401658-2267D3D0-C751-4BAC-A6C2-2BB0F6578B28Q30401669-D5E590CB-782C-4A19-A75C-619C9A6D5C37Q30404095-3B97B625-B709-4E72-92C9-7A2E137E35C5Q30404203-A2917068-EC40-4697-AB83-AAB6FE9F1807Q30404670-8E45891D-9D22-4FB2-978E-6D732E201E7F
P2860
Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Protection of mice against let ...... cal swine H1N1 based vaccines.
@ast
Protection of mice against let ...... cal swine H1N1 based vaccines.
@en
type
label
Protection of mice against let ...... cal swine H1N1 based vaccines.
@ast
Protection of mice against let ...... cal swine H1N1 based vaccines.
@en
prefLabel
Protection of mice against let ...... cal swine H1N1 based vaccines.
@ast
Protection of mice against let ...... cal swine H1N1 based vaccines.
@en
P2093
P2860
P50
P1433
P1476
Protection of mice against let ...... ical swine H1N1 based vaccines
@en
P2093
Silke Stertz
Tshidi Tsibane
P2860
P304
P356
10.1371/JOURNAL.PPAT.1000745
P50
P577
2010-01-29T00:00:00Z